Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation
Top Cited Papers
- 4 June 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (23), 9161-9166
- https://doi.org/10.1073/pnas.1202916109
Abstract
Hydrogen sulfide (H2S) is a unique gasotransmitter, with regulatory roles in the cardiovascular, nervous, and immune systems. Some of the vascular actions of H2S (stimulation of angiogenesis, relaxation of vascular smooth muscle) resemble those of nitric oxide (NO). Although it was generally assumed that H2S and NO exert their effects via separate pathways, the results of the current study show that H2S and NO are mutually required to elicit angiogenesis and vasodilatation. Exposure of endothelial cells to H2S increases intracellular cyclic guanosine 5'-monophosphate (cGMP) in a NO-dependent manner, and activated protein kinase G (PKG) and its downstream effector, the vasodilator-stimulated phosphoprotein (VASP). Inhibition of endothelial isoform of NO synthase (eNOS) or PKG-I abolishes the H2S-stimulated angiogenic response, and attenuated H2S-stimulated vasorelaxation, demonstrating the requirement of NO in vascular H2S signaling. Conversely, silencing of the H2S-producing enzyme cystathionine-gamma-lyase abolishes NO-stimulated cGMP accumulation and angiogenesis and attenuates the acetylcholine-induced vasorelaxation, indicating a partial requirement of H2S in the vascular activity of NO. The actions of H2S and NO converge at cGMP; though H2S does not directly activate soluble guanylyl cyclase, it maintains a tonic inhibitory effect on PDE5, thereby delaying the degradation of cGMP. H2S also activates PI3K/Akt, and increases eNOS phosphorylation at its activating site S1177. The cooperative action of the two gasotransmitters on increasing and maintaining intracellular cGMP is essential for PKG activation and angiogenesis and vasorelaxation. H2S-induced wound healing and microvessel growth in matrigel plugs is suppressed by pharmacological inhibition or genetic ablation of eNOS. Thus, NO and H2S are mutually required for the physiological control of vascular function.Keywords
This publication has 41 references indexed in Scilit:
- Use of the mouse aortic ring assay to study angiogenesisNature Protocols, 2011
- Hydrogen Sulfide as Endothelium-Derived Hyperpolarizing Factor Sulfhydrates Potassium ChannelsCirculation Research, 2011
- Hydrogen sulphide and angiogenesis: mechanisms and applicationsBritish Journal of Pharmacology, 2011
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial functionProceedings of the National Academy of Sciences of the United States of America, 2011
- Hydrogen Sulfide and Cell SignalingAnnual Review of Pharmacology and Toxicology, 2011
- Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potentialExpert Review of Clinical Pharmacology, 2011
- Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease.2011
- PKG-I inhibition attenuates vascular endothelial growth factor-stimulated angiogenesisVascular Pharmacology, 2010
- Hydrogen Sulfide Is an Endogenous Inhibitor of Phosphodiesterase ActivityArteriosclerosis, Thrombosis, and Vascular Biology, 2010